Fabio Cacciapaglia

2.7k total citations
98 papers, 1.7k citations indexed

About

Fabio Cacciapaglia is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Fabio Cacciapaglia has authored 98 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Rheumatology, 24 papers in Immunology and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Fabio Cacciapaglia's work include Systemic Lupus Erythematosus Research (25 papers), Rheumatoid Arthritis Research and Therapies (25 papers) and Systemic Sclerosis and Related Diseases (14 papers). Fabio Cacciapaglia is often cited by papers focused on Systemic Lupus Erythematosus Research (25 papers), Rheumatoid Arthritis Research and Therapies (25 papers) and Systemic Sclerosis and Related Diseases (14 papers). Fabio Cacciapaglia collaborates with scholars based in Italy, United States and Switzerland. Fabio Cacciapaglia's co-authors include G. Di Chiara, Valentina Valentini, R. Mark Wightman, Regina M. Carelli, Daniele Lecca, Antonella Afeltra, Michael P. Saddoris, Florenzo Iannone, Elio Acquas and Marco Fornaro and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Biological Psychiatry.

In The Last Decade

Fabio Cacciapaglia

84 papers receiving 1.6k citations

Peers

Fabio Cacciapaglia
Nobuyuki Oka Japan
Alfredo Damasceno Brazil
Jonathan Katz United States
Marco Rizzo United States
Jon Lampa Sweden
Ivana Novaković Serbia
Nardo Nardocci Italy
Maria Donata Benedetti Italy
Valerie B. O’Leary Ireland
Ron Dabby Israel
Nobuyuki Oka Japan
Fabio Cacciapaglia
Citations per year, relative to Fabio Cacciapaglia Fabio Cacciapaglia (= 1×) peers Nobuyuki Oka

Countries citing papers authored by Fabio Cacciapaglia

Since Specialization
Citations

This map shows the geographic impact of Fabio Cacciapaglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Cacciapaglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Cacciapaglia more than expected).

Fields of papers citing papers by Fabio Cacciapaglia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Cacciapaglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Cacciapaglia. The network helps show where Fabio Cacciapaglia may publish in the future.

Co-authorship network of co-authors of Fabio Cacciapaglia

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Cacciapaglia. A scholar is included among the top collaborators of Fabio Cacciapaglia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Cacciapaglia. Fabio Cacciapaglia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartoloni, Elena, Fabio Cacciapaglia, Gian Luca Erre, et al.. (2025). Immunomodulation for accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Autoimmunity Reviews. 24(4). 103760–103760.
2.
Battista, Marco Di, Antonina Minniti, Giuseppe Armentaro, et al.. (2025). Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study. Lara D. Veeken. 64(10). 5364–5371.
3.
Cacciapaglia, Fabio, et al.. (2024). Modulation of IL-6 receptor/STAT3 downstream signaling in rheumatoid arthritis patients. Experimental and Molecular Pathology. 141. 104951–104951. 3 indexed citations
4.
5.
Landi, Lorenza, Silvia Bellando-Randone, Clodoveo Ferri, et al.. (2024). OP0023 TOWARDS A COMPREHENSIVE APPROACH TO THE MANAGEMENT AND PROGNOSIS OF SYSTEMIC SCLEROSIS PATIENTS: THE ROLE OF COMORBIDITIES IN THE SPRING-SIR REGISTRY. Annals of the Rheumatic Diseases. 83. 68–68.
6.
Cacciapaglia, Fabio, Francesca Romana Spinelli, Elena Bartoloni, et al.. (2023). Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group. Journal of Clinical Medicine. 12(6). 2148–2148. 6 indexed citations
7.
Atzeni, Fabiola, Fabio Cacciapaglia, James Galloway, et al.. (2023). Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort. Autoimmunity Reviews. 23(2). 103478–103478. 1 indexed citations
8.
Spinelli, Francesca Romana, Fabrizio Conti, Roberto Caporali, Florenzo Iannone, & Fabio Cacciapaglia. (2023). Janus kinase inhibitors: between prescription authorization and reimbursability. SHILAP Revista de lepidopterología. 75(4). 1 indexed citations
9.
Cacciapaglia, Fabio, Paolo Airó, Marco Fornaro, et al.. (2022). Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients. Lara D. Veeken. 62(4). 1552–1558. 6 indexed citations
10.
Cacciapaglia, Fabio, Francesca Romana Spinelli, Gian Luca Erre, et al.. (2022). Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society of Rheumatology. Clinical and Experimental Rheumatology. 41(9). 1784–1791. 6 indexed citations
11.
Erre, Gian Luca, Fabio Cacciapaglia, Garifallia Sakellariou, et al.. (2022). C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis. European Journal of Internal Medicine. 104. 49–54. 28 indexed citations
12.
Giuggioli, Dilia, Cosimo Bruni, Fabio Cacciapaglia, et al.. (2021). Pulmonary arterial hypertension: guidelines and unmet clinical needs. SHILAP Revista de lepidopterología. 72(4). 228–246. 9 indexed citations
13.
Carbone, Federico, Fabrizio Montecucco, Alessandro Poggi, et al.. (2020). Serum adiponectin levels are associated with presence of carotid plaque in women with systemic lupus erythematosus. Nutrition Metabolism and Cardiovascular Diseases. 30(7). 1147–1151. 8 indexed citations
14.
Costa, Luisa, Roberta Ramonda, Augusta Ortolan, et al.. (2019). Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment. Clinical Rheumatology. 38(9). 2355–2362. 14 indexed citations
15.
Cacciapaglia, Fabio, Maria Grazia Anelli, Daniela Rizzo, et al.. (2016). Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients. Reumatismo. 67(3). 97–102. 14 indexed citations
16.
Saddoris, Michael P., Fabio Cacciapaglia, R. Mark Wightman, & Regina M. Carelli. (2015). Differential Dopamine Release Dynamics in the Nucleus Accumbens Core and Shell Reveal Complementary Signals for Error Prediction and Incentive Motivation. Journal of Neuroscience. 35(33). 11572–11582. 135 indexed citations
17.
Cacciapaglia, Fabio, Cristiano Spadaccio, Chiara Gregorj, et al.. (2010). Apoptosis and Autoimmunity Induced by Clodronate in Systemic Lupus Erythematosus Mononuclear Circulating Cells. International Journal of Immunopathology and Pharmacology. 23(2). 535–542. 6 indexed citations
18.
Cacciapaglia, Fabio, Marta Vadacca, G. Coppolino, et al.. (2007). Spontaneous splenorenal shunt in a patient with antiphospholipid syndrome: the first case reported. Lupus. 16(1). 56–58. 8 indexed citations
19.
Amoroso, Antonio, Fabio Cacciapaglia, G. Coppolino, et al.. (2006). The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement.. PubMed. 24(3). 287–94. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuyuki Oka Breakdown of academic impact, for papers by Alfredo Damasceno Breakdown of academic impact, for papers by Jonathan Katz Breakdown of academic impact, for papers by Marco Rizzo Breakdown of academic impact, for papers by Jon Lampa Breakdown of academic impact, for papers by Ivana Novaković Breakdown of academic impact, for papers by Nardo Nardocci Breakdown of academic impact, for papers by Maria Donata Benedetti Breakdown of academic impact, for papers by Valerie B. O’Leary Breakdown of academic impact, for papers by Ron Dabby
Rankless by CCL
2026